Flash FinanceUS
After hours S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Outset Medical, Inc. (OM)

Outset Medical General Counsel John Brottem to depart effective September 11, 2026

Neutral Impact 2 of 5 leadership Written later

Outset Medical said General Counsel John Brottem informed the company on August 27, 2026, that he will leave his role effective September 11, 2026, to pursue other professional opportunities. The filing states the departure is not due to any dispute or disagreement with the company or its management.

Key points

  • John Brottem gave notice on August 27, 2026, and his departure as General Counsel is effective September 11, 2026.
  • He is leaving to pursue other professional opportunities.
  • The filing says the departure is not due to any dispute or disagreement with the company or its management.

The filing

CompanyOutset Medical, Inc. (OM)
Form8-K, current report
Filed with the SECAug 28, 2026, 4:05 PM ET
Accession number0001193125-26-374323

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 28, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.